This test is most useful if any of these apply to you.
If you work around solvents, degreasers, or spray adhesives, this urine marker answers a specific question: is a chemical called 1-bromopropane actually getting into your body right now? It is one of the clearest ways to tell whether your exposure is real and current, rather than something you can only guess at from job title or smell.
This matters because 1-bromopropane has been tied in human studies to faster loss of lung function and, at high workplace doses, to nerve damage. A single result reflects mostly recent exposure, usually the last day or so at typical levels, which makes it a practical early check before symptoms appear.
This test measures NAPR (N-acetyl-S-propyl-cysteine), sometimes written AcPrCys or BPMA, in urine. It is not the solvent itself. It is what your body produces after it grabs the solvent with a built-in protective molecule (glutathione, your cells' main cleanup helper) and repackages it for disposal.
This disposal route, called the mercapturic acid pathway, is how your body neutralizes many reactive industrial chemicals and flushes them out through the kidneys. Because the end product leaves in urine quickly, a high level points to recent internal dose, not a lifetime of buildup. In plain terms, the number tells you how much 1-bromopropane your body has been dealing with lately.
1-bromopropane (1-BP) is used as a substitute for older ozone-depleting solvents. The best-documented sources are vapor degreasing (cleaning metal parts), spray adhesives used in foam cushion and furniture manufacturing, and general cleaning solvents. In studies of these workplaces, the main route into the body was breathing the vapor.
In one workplace study, people stationed near degreasing machines carried roughly ten times more of this marker in their urine over two days than coworkers positioned away from the equipment. That gap tracked closely with how much solvent was measured in the air they breathed, which is why the urine level is treated as a reliable stand-in for real exposure.
The strongest human evidence links this marker to breathing capacity. In a study of about 3,300 urban adults in China, higher levels were tied to lower scores on two standard breathing measures: the total amount of air you can forcibly exhale (FVC) and how much you can blow out in the first second (FEV1).
Each tripling of the marker was linked to roughly 30 mL less FVC and 26 mL less FEV1. On its own that is small, but the tracking part is what stands out: people whose levels stayed high over three years lost about 79 mL of FVC and 50 mL of FEV1 per year. That is faster than typical age-related decline, which averages somewhere around 30 mL a year in healthy nonsmokers but varies with sex and age (men tend to decline faster than women, and estimates for FVC range from roughly 22 to 36 mL a year). Part of that lung effect appeared to run through oxidative damage to DNA, a marker of chemical wear and tear on cells.
What this means for you: if your level is elevated and you have any cough, breathlessness, or a physically demanding job, a breathing test (spirometry) is a reasonable companion check, and reducing the exposure is worth acting on before decline becomes noticeable.
At heavy occupational exposure, 1-bromopropane can damage nerves. In a cluster of six golf-club cleaning workers exposed to high solvent levels, this marker was detectable in urine 5 to 26 days after exposure, alongside tingling pain, soreness in the legs, and abnormal sensations. The outbreak was traced to failed ventilation fans and inadequate protective equipment.
This evidence comes from a small case series, not a large population, so it describes what can happen with intense exposure rather than everyday background levels. Still, new numbness, tingling, or weakness in someone with a known solvent job deserves both this test and a neurological evaluation.
One large US general-population survey found that this specific marker showed a small, statistically insignificant negative link with chronic obstructive pulmonary disease, even though the broader mix of solvent metabolites was tied to about 30% higher odds of the disease. That looks like a contradiction with the lung-function findings above, but it is not.
The difference comes down to who was studied. A general survey captures mostly very low, incidental background exposure measured once, with no control over timing, so weak or scrambled associations are expected. The lung-decline signal came from people with higher, repeatedly measured exposure. Lower is still better here: the odd negative correlation is a statistical quirk of a low-exposure population, not evidence that the solvent protects your lungs.
Because your body clears these urine breakdown products quickly, this test reads recent exposure, usually the prior hours to a day at typical levels. An exact clearance time for this specific marker has not been pinned down in people, but closely related mercapturic acids peak within a few hours of exposure and largely clear within 12 to 48 hours. After very heavy exposure, however, this marker has stayed detectable for as long as 5 to 26 days, so a single low reading is most reassuring when exposure has been light.
The practical consequence: a low result collected days after you were last near the solvent does not prove you are exposure-free during your working weeks. To catch real workplace exposure, timing of the sample relative to your last shift matters more than almost anything else.
A single value captures a snapshot of recent exposure and little else. In a repeat-testing panel, this marker showed fair to good stability across three days to three years, which means levels genuinely rise and fall with your exposure rather than staying fixed. That variability is exactly why a trend beats a one-time number.
A sensible approach: get a baseline now, ideally near the end of a work shift when exposure would be highest. If you make changes at work, retest within a few weeks to confirm the level actually dropped. For anyone with ongoing solvent exposure, repeat at least a few times a year, and retest after any change to ventilation, equipment, or protective gear.
An elevated level is a prompt to find and cut the source. Review the products and processes you work with, check safety data sheets for 1-bromopropane, and involve an occupational medicine physician or industrial hygienist who can assess your workplace directly. This is a solvable exposure once the source is identified.
Pair the result with the right companion checks based on your symptoms. Add a urinary oxidative DNA damage marker to gauge cellular stress, order spirometry if you have any breathing symptoms, and pursue a neurological evaluation for numbness or tingling. Then retest this marker after reducing exposure to confirm the number is coming down.
Evidence-backed interventions that affect your NAPR level
N-Acetyl (Propyl) Cysteine is best interpreted alongside these tests.
N-Acetyl (Propyl) Cysteine is included in these pre-built panels.